Knight Therapeutics Inc. Stock OTC Markets
Stocks
KHTRF
CA4990531069
Pharmaceuticals
OTC Markets Traded|
Market Closed -
OTC Markets
10:45:54 2026-09-08 EDT
|
5-day change | 1st Jan Change | ||
| 7.150 USD | -1.24% |
|
-1.24% | +64.37% |
| 09-02 | Knight Therapeutics Gets Regulatory Approval for TAVALISSE in Colombia | MT |
| 09-01 | Knight Therapeutics Announces Regulatory Approval of Tavalisse in Colombia | CI |
| Market Cap | 984M 707M 613M 579M 524M 67.84B 992M 6.91B 2.66B 34.4B 2.66B 2.6B 110B | P/E 2026 * |
72x | P/E 2027 * | 37.4x |
|---|---|---|---|---|---|
| Enterprise Value | 984M 707M 613M 579M 524M 67.84B 992M 6.91B 2.66B 34.4B 2.66B 2.6B 110B | EV / Sales 2026 * |
1.78x | EV / Sales 2027 * | 1.79x |
| Free-Float |
53.99% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| GUD | Delayed | |
OTC Markets
| KHTRF | Delayed | |
|
Deutsche Boerse AG
| 04K | Delayed | |
|
Tradegate
| 04K | Real-time | |
|
Boerse Muenchen
| 04K | Real-time | |
|
Börse Stuttgart
| 04K | Delayed |
Last Transcript: Knight Therapeutics Inc.
| 1 day | -1.24% | ||
| 1 week | -1.24% | ||
| Current month | +4.08% | ||
| 1 month | +7.26% | ||
| 3 months | +5.77% | ||
| 6 months | +65.51% | ||
| Current year | +64.37% |
| 1 month | 6.77 |  | 7.26 |
| Current year | 4.19 | | 7.4 |
| 1 year | 4.07 | | 7.4 |
| 3 years | 3.2 | | 7.4 |
| 5 years | 3.19 | | 7.4 |
| 10 years | 3.19 | | 8.33 |
| Manager | Title | Age | Since |
|---|---|---|---|
Samira Sakhia
CEO | Chief Executive Officer | 57 | 2021-08-31 |
Arvind Utchanah
DFI | Director of Finance/CFO | - | 2020-03-29 |
Melanie Groleau
CTO | Chief Tech/Sci/R&D Officer | - | 2019-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Jonathan Goodman
CHM | Chairman | 58 | 2021-08-31 |
James Gale
CHM | Chairman | 77 | - |
Robert Lande
BRD | Director/Board Member | 63 | 2012-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.24% | -1.24% | - | - | 707M | |
| -0.15% | -4.35% | +73.64% | +32.84% | 357B | |
| +0.27% | -3.11% | +22.62% | -20.57% | 65.51B | |
| -1.57% | -3.58% | +38.17% | +162.22% | 12.25B | |
| +0.70% | -6.23% | -8.49% | -16.91% | 7.54B | |
| -1.26% | -8.12% | -29.64% | -16.02% | 4.6B | |
| +0.25% | -1.73% | -33.75% | +9.70% | 4.38B | |
| -1.13% | -4.33% | -34.67% | -10.64% | 2.93B | |
| -0.51% | -5.17% | -9.19% | +40.98% | 2.41B | |
| -0.28% | -3.22% | -27.62% | -29.52% | 1.93B | |
| Average | -0.52% | -3.59% | -0.99% | +16.90% | 50.99B | |
| Weighted average by Cap. | -0.36% | -3.61% | +60.45% | +26.65% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 552M 397M 344M 325M 294M 38.07B 557M 3.88B 1.49B 19.3B 1.49B 1.46B 61.57B | 549M 395M 342M 323M 293M 37.85B 553M 3.86B 1.48B 19.19B 1.48B 1.45B 61.2B |
| Net income | 13.32M 9.57M 8.29M 7.84M 7.1M 918M 13.42M 93.53M 35.99M 465M 35.94M 35.15M 1.48B | 26.36M 18.94M 16.41M 15.52M 14.05M 1.82B 26.56M 185M 71.24M 921M 71.16M 69.58M 2.94B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GUD Stock
- KHTRF Stock
Select your edition
All financial news and data tailored to specific country editions
